| Phase I/II Randomized Study of Stereotactic Ablative Radiotherapy (SABR) Versus Standard of Care for Refractory Structural Cardiac Arrhythmias (SABR-HEART) (NCT05084391) | M.D. Anderson Cancer Center | 2019-09-12 |
| First in Human Study of Ziftomenib in Relapsed or Refractory Acute Myeloid Leukemia (NCT04067336) | Kura Oncology, Inc. | 2019-09-12 |
| Nivolumab Combined With BMS-986253 in HCC Patients (NCT04050462) | NYU Langone Health | 2019-09-12 |
| A Trial of Safety/Efficacy of Test Article in Patients With Interdigital T. Pedis (NCT04315051) | DermBiont, Inc. | 2019-09-12 |
| Dose-range Finding Efficacy and Safety Study for QBW251 in COPD Patients (NCT04072887) | Novartis Pharmaceuticals | 2019-09-12 |
| Glioblastoma Treatment With Irradiation and Olaptesed Pegol (NOX-A12) in MGMT Unmethylated Patients (NCT04121455) | TME Pharma AG | 2019-09-12 |
| Treatment of Refractory Systemic Lupus Erythematosus by Allogeneic Mesenchymal Stem Cells Derived From the Umbilical Cord (NCT03562065) | Assistance Publique - Hôpitaux de Paris | 2019-09-11 |
| A Phase 2 Study of CIN-102 in Adults With Idiopathic and Diabetic Gastroparesis (NCT04026997) | CinDome Pharma, Inc. | 2019-09-11 |
| Phase 2 Study of Dacomitinib in NSCLC (NCT04027647) | National Cancer Centre, Singapore | 2019-09-11 |
| Phase 2 Study of TVB-2640 in KRAS Non-Small Cell Lung Carcinomas (NCT03808558) | David E Gerber | 2019-09-11 |
| Protectivity and Safety Following Recombinant Hepatitis B Vaccine (NCT03919578) | PT Bio Farma | 2019-09-11 |
| Intraoral Administration of Botox in Patients With Dentoalveolar Neuropathic Pain (NCT03848143) | Isabel Moreno Hay | 2019-09-11 |
| An Open Label Study of Bavituximab and Pembrolizumab in Advanced Gastric and GEJ Cancer Patients (NCT04099641) | OncXerna Theraputics, Inc. | 2019-09-11 |
| A Depot Formulation of Sunitinib Malate (GB-102) in Subjects With Diabetic Macular Edema and Retinal Vein Occlusion (NCT04085341) | Graybug Vision | 2019-09-11 |
| LMB-100 Followed by Pembrolizumab in the Treatment of Adults With Mesothelin-Expressing Non-Squamous Non-Small Cell Lung Cancer (NSCLC) (NCT04027946) | National Cancer Institute (NCI) | 2019-09-11 |
| Combining Active and Passive DNA Hypomethylation (NCT03999723) | Kirsten Grønbæk | 2019-09-11 |
| Efficacy of First Line B-RI for Treatment Naive Waldenström's Macroglobulinemia (NCT03620903) | Christian Buske | 2019-09-11 |
| Sintilimab Combined With Anlotinib as Second or Further-line Therapy for ED-SCLC (NCT04055792) | Henan Cancer Hospital | 2019-09-11 |
| L-arginine Study for Persistent Symptoms of Schizophrenia (NCT04054973) | University of Massachusetts, Worcester | 2019-09-11 |
| 1% Chloroprocaine(PF) vs. Bupivacaine Spinals (NCT03324984) | Montefiore Medical Center | 2019-09-11 |
| Efficacy and Safety of Low-dose IL-2 in Patients With SLE: a Multicenter, Randomised, Placebo-controlled Trial (NCT04077684) | Peking University People's Hospital | 2019-09-10 |
| Chinese Medicine Treat for Hypertensive Renal Injury (NCT04078711) | Jiangsu Province Hospital of Traditional Chinese Medicine | 2019-09-10 |
| FOLFOXIRI With or Without Intensification for Rectal Cancer (NCT03997435) | CCTU | 2019-09-10 |
| Genotype and Phenotype Guided Supplementation of TAMoxifen Standard Therapy With ENDOXifen in Breast Cancer Patients (NCT03931928) | Robert Bosch Gesellschaft für Medizinische Forschung mbH (RBMF) | 2019-09-10 |
| A Phase II Study to Evaluate the Efficacy and Safety of MT921 in Subjects With Moderate to Severe Submental Fat (NCT04144049) | Medy-Tox | 2019-09-10 |
| Assessing An Oral Janus Kinase Inhibitor, AZD4205 as Monotherapy in Patients Who Have PTCL (JACKPOT8) (NCT04105010) | Dizal Pharmaceuticals | 2019-09-10 |
| Anti-PD-1 Antibody Combined With Pegaspargase in the Treatment of Advanced Stage NK/T-cell Lymphoma (NCT04096690) | Ruijin Hospital | 2019-09-10 |
| Bazedoxifene Acetate as a Remyelinating Agent in Multiple Sclerosis (NCT04002934) | Riley Bove, MD | 2019-09-10 |
| A Study to Evaluate the Efficacy and Safety of Anti-PD-1 Antibody AK105 in Patients With Selected Advanced Solid Tumors (NCT04172506) | Akeso | 2019-09-10 |
| Safety, Immunogenicity and Preliminary Clinical Activity Study of PDC*lung01 Cancer Vaccine in NSCLC (NCT03970746) | PDC*line Pharma SAS | 2019-09-10 |
| PTI-125 for Mild-to-moderate Alzheimer's Disease Patients (NCT04079803) | Cassava Sciences, Inc. | 2019-09-09 |
| Clobetasol Topical Oil for Children With Moderate to Severe Atopic Dermatitis (NCT03847389) | Hill Dermaceuticals, Inc. | 2019-09-09 |
| A Study of FMT in Patients With AML Allo HSCT in Recipients (NCT03678493) | Masonic Cancer Center, University of Minnesota | 2019-09-09 |
| Pyrotinib or Trastuzumab Plus Nab-paclitaxel as Neoadjuvant Therapy in HER2-positive Breast Cancer (NCT04066790) | Shanghai Jiao Tong University School of Medicine | 2019-09-09 |
| Suppression Of Bacterial Vaginosis (BV) [SUBVert] (NCT03930745) | National Institute of Allergy and Infectious Diseases (NIAID) | 2019-09-09 |
| Phase II Study of Neoadjuvant Immune Checkpoint Inhibitor in Patients With Resectable Gastrointestinal Cancers (NCT04196465) | Asan Medical Center | 2019-09-09 |
| Use of Gallium-68 HA-DOTATATE PET/CT in Giant Cell Arteritis (GCA) (NCT03812302) | University of Alberta | 2019-09-09 |
| Subacromial Methylprednisolone Versus Ketorolac for Shoulder Impingement (NCT03913702) | The University of Texas Medical Branch, Galveston | 2019-09-09 |
| Pistachios Blood Sugar Control, Heart and Gut Health (NCT04056208) | Penn State University | 2019-09-09 |
| A Study Evaluating the Efficacy and Safety of AP30663 for Cardioversion in Participants With Atrial Fibrillation (AF) (NCT04571385) | Acesion Pharma | 2019-09-09 |
| Intranasal Insulin in Frontotemporal Dementia (FTD) (NCT04115384) | HealthPartners Institute | 2019-09-09 |
| Salvage Oligometastasectomy and Radiation Therapy in Recurrent Prostate Cancer (NCT03796767) | University of Utah | 2019-09-09 |
| Effect of Vitamin D Supplementation on Improvement of Pneumonic Children (NCT04244474) | Cairo University | 2019-09-09 |
| Outcomes for Lumbar Decompressions With Use of Liposomal Bupivicaine (NCT04066296) | University of Colorado, Denver | 2019-09-08 |
| A Study of Toripalimab Combined With Concurrent Chemoradiotherapy for Locally Advanced Esophageal Squamous Cell Carcinoma. (NCT04084158) | Zhejiang Cancer Hospital | 2019-09-07 |
| Uromune in Treating Recurrent Urinary Tract Infections in Women (NCT04096820) | Queen's University | 2019-09-06 |
| A Phase II Trial of Neoadjuvant Treatment With PD-1 Inhibition (Nivolumab) With or Without IDO Inhibition (BMS-986205) and With or Without CTLA-4 Inhibition (Ipilimumab) in Resectable Stage III or IV Melanoma (NCT04007588) | Dana-Farber Cancer Institute | 2019-09-06 |
| Adaptation of Thirst to a Single Administration of Tolvaptan (TOLVATHIRST) (NCT03931369) | Assistance Publique - Hôpitaux de Paris | 2019-09-06 |
| Niraparib in Combination With Trastuzumab in Metastatic HER2+ Breast Cancer (NCT03368729) | University of Alabama at Birmingham | 2019-09-06 |
| FOLFIRI as Salvage Treatment in Metastatic Biliary Tract Cancer (BTC) Patients Who Were Failed After Gemcitabine Containing Chemotherapy: A Phase II Single Arm Prospective Study (NCT03110510) | Samsung Medical Center | 2019-09-06 |
| Safety and Proof-of-Concept (POC) Study With AMT-130 in Adults With Early Manifest Huntington's Disease (NCT04120493) | UniQure Biopharma B.V. | 2019-09-06 |
| An Investigational Immunotherapy Study of BMS-986288 Alone and in Combination With Nivolumab in Advanced Solid Cancers (NCT03994601) | Bristol-Myers Squibb | 2019-09-06 |
| A Study to Assess the Safety and Efficacy of 5-aminolevulinic Acid Hydrochloride (5-ALA HCl) and Sodium Ferrous Citrate (SFC) Added on Artemisinin-based Combination Therapy (ACT) in Adult Patients With Uncomplicated Malaria (NCT04020653) | Neopharma Japan Co., Ltd. | 2019-09-06 |
| Investigating the Safety and Efficacy of Rituximab and Pembrolizumab in Relapsed/Refractory Waldenström's Macroglobulinaemia (NCT03630042) | University College, London | 2019-09-06 |
| A Randomized Phase II Trial of Surgery Plus Sorafenib vs. Sorafenib Alone for Hepatocellular Cancer (HCC) With Portal Vein Invasion (NCT03971201) | White Plains Hospital | 2019-09-06 |
| Preservation of Swallowing in Respected Oral Cavity Squamous Cell Carcinoma: Examining Radiation Volume Effects (PRESERVE): A Randomized Trial (NCT03997643) | London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's | 2019-09-06 |
| Azithromycin a Treatment for Pulmonary Sarcoidosis (NCT04020380) | Hull University Teaching Hospitals NHS Trust | 2019-09-06 |
| Nivolumab in Patients With Advanced Cutaneous Squamous Cell Carcinoma (NCT03834233) | Instituto do Cancer do Estado de São Paulo | 2019-09-05 |
| LY3023414 and Prexasertib in Metastatic Triple-negative Breast Cancer (NCT04032080) | Baylor Research Institute | 2019-09-05 |
| RevErsing Poor GrAft Function With eLtrombopag After allogeneIc Hematopoietic Cell trAnsplantation (NCT03948529) | University Hospital, Lille | 2019-09-05 |
| A Behavioral Activation Intervention Administered in a College Freshman Orientation Course (NCT04038190) | University of Kansas | 2019-09-05 |
| Sildenafil Exercise: Role of PDE5 Inhibition (NCT04039087) | National Jewish Health | 2019-09-05 |
| Study of Folfiri/Cetuximab in FcGammaRIIIa V/V Stage IV Colorectal Cancer Patients (NCT03874026) | National Cancer Institute, Naples | 2019-09-05 |
| A Study of CLE-100 (Oral Esketamine) in Addition to Standard Antidepressant Drug for Major Depressive Disorder - CLEO Study (NCT04103892) | Clexio Biosciences Ltd. | 2019-09-05 |
| VR for Burn Dressing Changes at Home (NCT04548635) | Nationwide Children's Hospital | 2019-09-05 |
| A Study of E7389 Liposomal Formulation (E7389-LF) Plus Nivolumab in Participants With Solid Tumor (NCT04078295) | Eisai Co., Ltd. | 2019-09-05 |
| Trial to Compare Efficacy and Safety of Chemotherapy/Quizartinib vs Chemotherapy/Placebo in Adults FMS-like Tyrosine Kinase 3 (FLT3) Wild-type Acute Myeloid Leukemia (AML) (NCT04107727) | PETHEMA Foundation | 2019-09-05 |
| Radiotherapy, Carboplatin/Paclitaxel and Nivolumab for High Risk HPV-related Head and Neck Cancer (NCT03829722) | University of Michigan Rogel Cancer Center | 2019-09-05 |
| K0706 for Patients Diagnosed With Dementia With Lewy Bodies (NCT03996460) | Georgetown University | 2019-09-05 |
| Autologous Volar Fibroblast Injection Into the Stump Site of Amputees (NCT03947450) | Johns Hopkins University | 2019-09-05 |
| Study of KN046 With Chemotherapy in First Line Advanced NSCLC (NCT04054531) | Jiangsu Alphamab Biopharmaceuticals Co., Ltd | 2019-09-04 |
| Investigation of Mechanisms of Action in Superpower Glass (NCT04049981) | Stanford University | 2019-09-04 |
| Efficacy and Safety Study of WVE-210201 (Suvodirsen) With Open-label Extension in Ambulatory Patients With Duchenne Muscular Dystrophy (NCT03907072) | Wave Life Sciences USA, Inc. | 2019-09-04 |
| Efficacy and Safety of Cannabidiol for Gastroparesis and Functional Dyspepsia (NCT03941288) | Mayo Clinic | 2019-09-04 |
| Combination Rucaparib With Nivolumab in Small Cell Lung Carcinoma (NCT03958045) | Zhonglin Hao | 2019-09-04 |
| Trikafta in Cystic Fibrosis Patients (NCT03506061) | Emory University | 2019-09-04 |
| N-Acetyl-L-Leucine for Niemann-Pick Disease, Type C (NPC) (NCT03759639) | IntraBio Inc | 2019-09-04 |
| Pembrolizumab for Patients With PD-L1 Diffuse Large B Cell Lymphoma (DLBCL) (NCT03990961) | University of Chicago | 2019-09-04 |
| A Clinical Trial Evaluating the Efficacy of Valganciclovir in Glioblastoma Patients (NCT04116411) | Cecilia Soderberg-Naucler | 2019-09-04 |
| Phase II Randomized Trial of Carboplatin+Pemetrexed+Bevacizumab+/- Atezolizumab in Stage IV NSCLC (NCT03786692) | Fox Chase Cancer Center | 2019-09-04 |
| Clarithromycin Mechanisms in Hypersomnia Syndromes (NCT04026958) | Emory University | 2019-09-04 |
| Postop Hypofractionated Radiation Therapy and LHRH in Patients With Prostate Cancer (NCT04249154) | McGill University Health Centre/Research Institute of the McGill University Health Centre | 2019-09-03 |
| Sarilumab in Patients With Glucocorticoid-Dependent Sarcoidosis (NCT04008069) | Stanford University | 2019-09-03 |
| IA14 Induction in Young Acute Myeloid Leukemia (NCT04069208) | Peking Union Medical College Hospital | 2019-09-03 |
| Evaluation the Treatment Outcome for RFA in Patients With BCLC Stage B HCC in Comparison With TACE (NCT03642561) | Fudan University | 2019-09-03 |
| Vitamin B6 and B12 in the Treatment of Movement Disorders Induced by Antipsychotics (NCT03790345) | Nucleo De Pesquisa E Desenvolvimento De Medicamentos Da Universidade Federal Do Ceara | 2019-09-03 |
| A Novel Pharmacological Therapy for Obstructive Sleep Apnea (NCT03919955) | Brigham and Women's Hospital | 2019-09-03 |
| Phase II Study of PRL3-ZUMAB in Advanced Solid Tumors (NCT04118114) | National Cancer Centre, Singapore | 2019-09-03 |
| Janus Kinase Inhibition to Prevent Ventilator-induced Diaphragm Dysfunction (NCT03681275) | Stanford University | 2019-09-03 |
| Biomarker Analysis of Castration-resistant Prostate Cancer Undergoing Treatment With Docetaxel Followed by Enzalutamide (NCT03700099) | Instituto do Cancer do Estado de São Paulo | 2019-09-03 |
| Gut Imaging for Function & Transit in Cystic Fibrosis Study 2 (NCT04006873) | Nottingham University Hospitals NHS Trust | 2019-09-03 |
| Immunogenicity & Safety of Bio Farma's Measles-Rubella (MR) Vaccine in Indonesian Infants (Bridging Study) (NCT04183114) | PT Bio Farma | 2019-09-03 |
| Comparison of SYN023 to Human Rabies Immune Globulin in Post Exposure Prophylaxis of Rabies (NCT03961555) | Synermore Biologics Co., Ltd. | 2019-09-03 |
| Treatment of Female Genital Schistosomiasis (FGS) With Praziquantel: A Proof-of-Concept Study (NCT04115072) | Regionshospital Nordjylland | 2019-09-03 |
| A Phase I/II Study of AST-3424 in Subjects With Advanced Solid Tumors (NCT06239155) | Ascentawits Pharmaceuticals, Ltd | 2019-09-03 |
| A Study of Evaluating the Safety and Efficacy of ATG-010 in Relapsed Refractory Multiple Myeloma (NCT03944057) | Antengene Corporation | 2019-09-02 |
| A Study to Determine If a New Shigella Vaccine is Safe, Induces Immunity and The Best Dose Among Kenyan Infants (NCT04056117) | LimmaTech Biologics AG | 2019-09-02 |
| Platelet-rich Plasma (PRP) Injection for Treatment of Erectile Function (NCT04050020) | Institute for the Study of Urological Diseases, Greece | 2019-09-02 |
| A Study to Assess the Safety and Efficacy of Probiotic to Modulate Psychological Stress (NCT04125810) | Danisco | 2019-09-02 |
| Cannabinoids for Taxane Induced Peripheral Neuropathy (NCT03782402) | New York State Psychiatric Institute | 2019-09-01 |